The MCED Inflection Point: What Galleri's FDA Panel Backing Means for Cancer Screening
Dr. Dereck Mush, MD, MBA
SkinVision
Develops a regulated smartphone application for early detection and monitoring of skin cancer.
What they do
SkinVision provides a regulated mobile application that enables individuals to assess their skin for signs of cancer. Consumers and insurers use the camera-based, AI-powered tool to analyze moles and lesions, receiving risk assessments and recommendations for dermatological follow-up care.
The record
- Vertical
- Oncology
- Sub-segment
- Cancer screening
- Product type
- Software as a medical device
- Stage
- Series B
- Headquarters
- Amsterdam, Netherlands
- Region
- Europe
- Founded
- 2011
- Total funding
- $10M raised
Notable investors: Leo Pharma, PHS Fund.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
PATHFINDER 2 Results: What the Galleri Multi-Cancer Blood Test Actually Found
Dr. Dereck Mush, MD, MBA
Screening Programs Are Rebuilding Around Reminder Systems That Actually Reach People
Dr. Dereck Mush, MD, MBA
Personalized Screening Versus Annual Mammography: What the Evidence Actually Compares
Dr. Dereck Mush, MD, MBA